The question hanging over High Tide heading into this report is not whether the company can grow, it clearly can, but whether the profit inflection at its German subsidiary Ramexian was a one-quarter fluke or the start of a durable pattern. That distinction matters enormously given how the last call was framed, and this quarter's numbers should go a long way toward settling it.
Consensus calls for revenue of $140.3 million, up 28.8% year over year, alongside EPS of a penny, flat against the same period last year. That growth rate represents a deceleration from the 30% pace management delivered last quarter, which itself was described as the fastest in eleven quarters, so the bar is still meaningfully elevated even if it has eased slightly. With no formal guidance range on the table, the Street is essentially extrapolating from the trajectory management laid out on the last call, particularly the monthly revenue run-rate at Ramexian, which scaled from $8 million to $10.5 million per month between the first and second quarters of fiscal 2026. Investors should want to see that run-rate continue climbing, ideally toward the 20% long-term German market share target management flagged, up from 14.1% as of the last print.